More on NRX
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.14 |
|
|||
| Open | $0.04 | ||||
| 52 Wk High | $8.90 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $0.14 | ||||
| Day Low | $0.14 | ||||
| P/E | N/A | ||||
| EPS | $-0.55 | ||||
| Volume | 805,757 | ||||
- NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
- NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
- NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
- NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
- NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
- Form D NurExone Biologic Inc.
- NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
- NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups
Entities mentioned with NRX
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- IPO | View Related Stories »
- Bankruptcy | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Pre-Open Losers | View Related Stories »
- Show More...
